Difference between revisions of "Lenograstim (Granocyte)"
Jump to navigation
Jump to search
m |
m |
||
| Line 7: | Line 7: | ||
==Also known as== | ==Also known as== | ||
| − | Neutrogin | + | *'''Brand names:''' Granocyte, Neutrogin |
[[Category:Drug index]] | [[Category:Drug index]] | ||
| − | [[Category: | + | [[Category:Subcutaneous medications]] |
| − | [[Category:Granulocyte | + | [[Category:Granulocyte colony-stimulating factors]] |
[[Category:Acute myeloid leukemia medications]] | [[Category:Acute myeloid leukemia medications]] | ||
| + | [[Category:EMA approved drugs]] | ||
| + | [[Category:PMDA approved drugs]] | ||
Revision as of 03:39, 17 November 2017
This drug is not available in the United States but is available internationally.
Diseases for which it is used
Note that colony stimulating factors are used for their adjuvant effect e.g. removing leukemia stem cells from their protective niches; they are not thought to have inherent anti-cancer activity.
Also known as
- Brand names: Granocyte, Neutrogin